drugset
drugset / Trial / NCT01638117

Cumulative Irritation Test of PAC-14028 in Healthy Volunteers

NCT01638117 ↗

Phase 1 Completed 35 enrolled Amorepacific Corporation
RandomizedParallel-groupQuadruple-blind

Summary

The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.

Timeline

Start
2012-04
Primary completion
2012-08
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject PAC-14028 Unknown 0.1 % Topical
Subject PAC-14028 Unknown 0.3 % Topical
Subject PAC-14028 Unknown 1 % Topical

Indications

No indication recorded.